The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and ...

Managing buffers in bioprocessing remains a largely manual process, requiring space and resources and often creating bottlenecks that increase costs and decrease efficiency. Researchers from many of ...

Nucleus Biologics launched the Krakatoa ® K500, which the company says is the first bioreactor-scale, pod-based media and buffer manufacturing system designed to deliver sterile solutions on demand ...

Discover valuable insights for transforming your biopharmaceutical production with our comprehensive resource. We take a deep dive into the latest industry trend of outsourcing buffer and process ...

Produces 35–500 liters of sterile media and buffers on demand at point-of-use, reducing cost, complexity, and lead times Pod-based, closed single-use system with integrated analytics, QR-code-driven ...

Helping pharmaceutical companies increase production efficiency and manage risk more effectively MOTIV is a buffer management technology for the vast majority of processes in pharmaceutical ...

The "Buffer Preparation Market Industry Trends and Global Forecasts to 2035: Distribution by Scale of Operation, Type of System Component, Type of Buffer Formulation, Type of Molecule, Type of ...

Helping pharmaceutical companies increase production efficiency and manage risk more effectively NEW YORK & CHICAGO--(BUSINESS WIRE)--Asahi Kasei Bioprocess America, subsidiary of diversified Japanese ...